Open AccessDose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics
Author(s) -
Volker Wacheck,
Peter Valent,
Michael Lahn,
Gemma Dickinson,
Wolfgang Fuereder,
Renata A. Meyer,
Susanne Herndlhofer,
Thorsten Fuereder,
Georg Dorfner,
Sada Pillay,
Valarie Andre,
Timothy P. Burkholder,
Jacqueline K. Akunda,
Wolfgang R. Sperr,
Leann Flye-Blakemore,
Dirk Van Bockstaele,
Richard F. Schlenk
Publication year - 2011
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s19341
Subject(s) - medicine , pharmacokinetics , myeloid leukemia , pharmacodynamics , clinical pharmacology , pharmacology , oncology